HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.

The FDA authorized marketing of 20 ZYN products as a lower risk than cigarettes, which drew immediate criticism from anti-cancer advocates.

One of the biggest themes for ATS this year is the dramatically growing role of AI in all aspects of pulmonary disease, ...

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.

Test your knowledge on changing approaches to managing patients with asthma outlined in the 2026 GINA asthma update.

Patients with cystic fibrosis often reduce or discontinue respiratory cotherapies after starting CFTR modulators without affecting clinical status.

Stool-based testing has poor sensitivity and low negative predictive value for colorectal cancer screening in patients with cystic fibrosis.

Divarasib demonstrated superior progression-free and overall survival compared with sotorasib or adagrasib in previously treated KRAS G12C NSCLC.

Anxiety and depression are common in patients with idiopathic pulmonary fibrosis and are significantly affected by the diagnostic criteria used.

Individuals who survive hematologic cancers are at high risk for subsequently developing cardiovascular disease.

Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.

The three largest Medicare Advantage insurers turned down requests for post-hospital care at some of the highest rates among major plans.